Final survival analysis of a phase 3 study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2-positive early or locally advanced breast cancerXavier Pivot,Mark D. Pegram,Javier Cortes,Diana Luftner,Gary H. Lyman,Giuseppe Curigliano,Igor M. Bondarenko,Mikhail Dvorkin,Jin Hee Ahn,Seock-Ah Im,Maria Litwiniuk,Yaroslav V. Shparyk,Gwo Fuang Ho,Nikolay V. Kislov,Marek Wojtukiewicz,Tomasz Sarosiek,Yee Soo Chae,Jin Seok Ahn,Hyerin Jang,Sujung Kim,Jiwon Lee,Soo Young Lee,Ye Chan YoonCANCER RESEARCH(2022)引用 2|浏览33暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要